Study shows how autoimmune diseases may be targeted using Treg-based cellular therapies

Study shows how autoimmune diseases may be targeted using Treg-based cellular therapies

Study shows how autoimmune diseases may be targeted using Treg-based cellular therapies

In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells (Treg) are instrumental in limiting the damage caused to the spinal cord in diseases like multiple sclerosis (MS).